The rise of copyright’s blockbuster initially sparked a boom for pharma, but recent changes present a uncertain picture for shareholders. Lower-cost versions are eroding revenue, and persistent legal battles add more https://jonaswrqj346964.ivasdesign.com/62336560/sildenafil-and-the-pharmaceutical-industry-a-volatile-investment